Theraclion Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Martin Deterre
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 1.5yrs |
| CEO ownership | n/a |
| Management average tenure | 1.2yrs |
| Board average tenure | 2.8yrs |
Recent management updates
Recent updates
CEO
Martin Deterre
1.5yrs
Tenure
Mr. Martin Deterre is Chief Executive Officer of Theraclion SA from May 2023. He was Director of Engineering and Development of Theraclion since 2020. He has successfully led the development of the new gen...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 2.8yrs | €472.00k | no data | |
| Chief Executive Officer | 1.5yrs | no data | no data | |
| Chief Financial Officer | less than a year | no data | no data | |
| Vice President of Operations | 2.8yrs | no data | no data | |
| VP Research & Chief Scientific Officer | less than a year | no data | no data | |
| Vice President of Sales & Business Development | no data | no data | no data | |
| Marketing & Customer Relations Director | less than a year | no data | no data | |
| VP of Veins & Chief Medical Officer | no data | no data | no data |
1.2yrs
Average Tenure
Experienced Management: TCLI.F's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 2.8yrs | €472.00k | no data | |
| Independent Director | 5.6yrs | no data | no data | |
| Member of the Board | 1.8yrs | no data | no data | |
| Independent Director | 5.6yrs | no data | no data | |
| Director | 3.4yrs | no data | no data | |
| Director | 2.8yrs | no data | no data | |
| Member of the Board | 1.8yrs | no data | no data |
2.8yrs
Average Tenure
Experienced Board: TCLI.F's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/11/23 02:51 |
| End of Day Share Price | 2024/08/26 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Theraclion SA is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Fanny Meindre | CIC Market Solutions (ESN) |
| Fanny Meindre | CIC Market Solutions (ESN) |
| Martial Descoutures | Invest Securities |